Health
Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination – News-Medical.Net
New research from a team of scientists in Australia finds that the second ‘booster’ dose of the Pfizer-BioNTech vaccine did not increase vaccine efficacy against…
New research from a team of scientists in Australia suggests that the second ‘booster’ dose of the Pfizer-BioNTech vaccine may not increase vaccine efficacy against severe acute respiratory syndrome (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19).
The results suggest one dose of the vaccine could be sufficient in providing a robust immune response 11 days after inoculation.
The findings could help shape policy as vaccine rollout has been slow in countries such as the United…
-
General21 hours agoAustralian economy still vulnerable to US bond turmoil
-
General7 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Business17 hours agoWhat I’d buy before the ASX rebounds: 3 high-conviction share picks
-
Noosa News6 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast